Product Information
QUDEXY XR 25 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $9.3250 per EA under NDC 00245107130. Its NADAC has been published 46 times since Feb 19, 2025.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245107130
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for QUDEXY XR 25 MG CAPSULE has been published 46 times since Feb 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3250 per EA |
|---|---|
| All-time high | $9.3373 (Mar 12, 2025) |
| All-time low | $9.3250 (Apr 23, 2025) |
| 52-week high | $9.3250 |
| 52-week low | $9.3250 |
| Median price | $9.3250 |
| Average price | $9.3271 |
| Largest weekly change | -0.1% (Apr 23, 2025) |
| Weeks tracked | 46 |
| Tracking since | Feb 19, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
-0.1%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUDEXY XR 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 25 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $9.3250 per EA (NDC 00245107130), effective Dec 31, 2025.
How has the price of QUDEXY XR 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUDEXY XR 25 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 46 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for QUDEXY XR 25 MG CAPSULE?
Since Feb 19, 2025, the NADAC for QUDEXY XR 25 MG CAPSULE has ranged from a low of $9.3250 (Apr 23, 2025) to a high of $9.3373 (Mar 12, 2025), with a median of $9.3250 per EA.
Are there cheaper alternatives to QUDEXY XR 25 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 25 MG SPRINKLE CAP, is $0.2547 per EA — about 97% below QUDEXY XR 25 MG CAPSULE.
Who manufactures QUDEXY XR 25 MG CAPSULE?
QUDEXY XR 25 MG CAPSULE (NDC 00245107130) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.